Mesa Laboratories, Inc. (NASDAQ:MLAB) declared a quarterly dividend on Thursday, July 6th, Wall Street Journal reports. Investors of record on Thursday, August 31st will be paid a dividend of 0.16 per share by the medical instruments supplier on Friday, September 15th. This represents a $0.64 dividend on an annualized basis and a dividend yield of 0.45%. The ex-dividend date is Tuesday, August 29th.

Mesa Laboratories has raised its dividend payment by an average of 3.9% annually over the last three years. Mesa Laboratories has a dividend payout ratio of 14.2% meaning its dividend is sufficiently covered by earnings. Equities analysts expect Mesa Laboratories to earn $3.78 per share next year, which means the company should continue to be able to cover its $0.64 annual dividend with an expected future payout ratio of 16.9%.

Shares of Mesa Laboratories (NASDAQ MLAB) traded down 0.31% during trading on Thursday, hitting $141.55. 15,379 shares of the company were exchanged. The firm has a market capitalization of $528.97 million, a PE ratio of 48.64 and a beta of 0.46. The firm’s 50-day moving average price is $146.98 and its 200 day moving average price is $131.82. Mesa Laboratories has a 12 month low of $102.14 and a 12 month high of $169.81.

Mesa Laboratories (NASDAQ:MLAB) last issued its quarterly earnings results on Wednesday, June 7th. The medical instruments supplier reported $1.24 EPS for the quarter, topping the consensus estimate of $1.00 by $0.24. The company had revenue of $24.30 million during the quarter, compared to analyst estimates of $27.10 million. Mesa Laboratories had a net margin of 11.94% and a return on equity of 17.67%. On average, equities research analysts expect that Mesa Laboratories will post $3.06 earnings per share for the current fiscal year.

In other Mesa Laboratories news, Director David M. Kelly sold 1,000 shares of Mesa Laboratories stock in a transaction on Monday, June 12th. The shares were sold at an average price of $142.00, for a total transaction of $142,000.00. Following the sale, the director now owns 4,750 shares of the company’s stock, valued at approximately $674,500. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, insider Glenn E. Adriance sold 4,000 shares of Mesa Laboratories stock in a transaction on Friday, June 9th. The stock was sold at an average price of $148.98, for a total transaction of $595,920.00. Following the sale, the insider now directly owns 10,000 shares in the company, valued at approximately $1,489,800. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 16,150 shares of company stock worth $2,292,899. 17.00% of the stock is currently owned by corporate insiders.

TRADEMARK VIOLATION WARNING: This report was originally posted by American Banking News and is the property of of American Banking News. If you are accessing this report on another publication, it was stolen and republished in violation of US & international copyright laws. The legal version of this report can be read at

Separately, Zacks Investment Research raised shares of Mesa Laboratories from a “hold” rating to a “buy” rating and set a $159.00 target price on the stock in a research note on Tuesday, June 13th.

About Mesa Laboratories

Mesa Laboratories, Inc is focused primarily on quality control products and services. The Company operates through four segments: Instruments, Continuous Monitoring, Biological Indicators and Cold Chain. The Instruments Division designs, manufactures and markets quality control instruments and disposable products.

Dividend History for Mesa Laboratories (NASDAQ:MLAB)

Receive News & Ratings for Mesa Laboratories Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mesa Laboratories Inc. and related companies with's FREE daily email newsletter.